Ilaris

This page shows the latest Ilaris news and features for those working in and with pharma, biotech and healthcare.

Novartis culls pipeline to focus on most transformative science

The company recently hit problems with one of its most important late-stage programmes, when the FDA refused to accept the filing of anti-inflammatory drug canakinumab (Ilaris) in cardiovascular risk

Latest news

Daily Brief: EULAR kicks off in Amsterdam, May brings together remainers and brexiteers and Autolus launches its IPOS

On today’s agenda expect new trial data from Novartis' Ilaris in gout, Lilly's Oluminant in systemic lupus and AbbVie's new JAK inhibitor upadacitinib.
CV data sets up Novartis' Ilaris for blockbuster sales

CV data sets up Novartis' Ilaris for blockbuster sales. Drug shown to reduce major adverse cardiovascular events. ... Novartis has posted surprise phase III data that could transform the fortunes of its anti-inflammatory drug Ilaris, making it an option
Novartis' Ilaris wins three new FDA approvals

Novartis' Ilaris wins three new FDA approvals. Immunotherapeutic expands in rare Periodic Fever Syndrome conditions. ... Novartis' anti-inflammatory therapy Ilaris (canakinumab) has received new US approvals for its use in three rare Periodic Fever
Novartis wins childhood arthritis indication for Ilaris in EU

Novartis wins childhood arthritis indication for Ilaris in EU. EC gives green light to drug for the treatment of systemic juvenile idiopathic arthritis. ... Novartis' inflammatory disease drug Ilaris (canakinumab) can be used more widely in the EU
Novartis lifts 2013 guidance on delay to Diovan generics

Jimenez also said Novartis had a fertile quarter in terms of its pipeline, with four approvals including Ilaris (canakinumab) for systemic juvenile idiopathic arthritis, Simbrinza (brinzolamide/brimonidine tartrate) for glaucoma, Lucentis

More from news
Approximately 4 fully matching, plus 8 partially matching documents found.

Latest appointments

AIMM Therapeutics appoints former Novartis VP Jan de Vries as CEO

During his time at Novartis, de Vries led the discovery and early development of several drugs including Elidel (pimecrolimus) for eczema, Ilaris (canakunimab) for cryopyrin-associated periodic syndromes, Gilenya (fingolimod) for

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Systematic Review Analyst - Oxford: Negotiable

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Medical/ Scientific Director: Salary TBC

Medical Writers: Competitive Salary and Benefits

Account Director: Excellent benefits

Senior Medical Writer: Great salary and benefits

Events Manager – Med Comms – Surrey: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Director development role to Business Director, H...: Excellent package

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Manager / Account Director: Competative

Associate Director, Market Access & HEOR – North-West: Negotiable

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Associate Editorial Director – Med Comms – London: Salary TBC

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Medical Writers Required – Cheshire: DOE

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Subscribe to our email news alerts

PMHub

Add my company

Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...